Macular Edema, Cystoid Completed Phase Trials for Nepafenac (DB06802)
Also known as: Cystoid Macular Edema / Cystoid macular oedema / Cystoid macular edema (disorder)
Indication | Status | Phase |
---|---|---|
DBCOND0027867 (Macular Edema, Cystoid) | Completed | Not Available |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03025945 | Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo | Treatment |